These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16689554)

  • 1. Data mining in the US using the Vaccine Adverse Event Reporting System.
    Iskander J; Pool V; Zhou W; English-Bullard R;
    Drug Saf; 2006; 29(5):375-84. PubMed ID: 16689554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing.
    Dong G; Bate A; Haguinet F; Westman G; Dürlich L; Hviid A; Sessa M
    Drug Saf; 2024 Feb; 47(2):173-182. PubMed ID: 38062261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mining adverse events in large frequency tables with ontology, with an application to the vaccine adverse event reporting system.
    Zhao B; Zhao L
    Stat Med; 2023 May; 42(10):1512-1524. PubMed ID: 36791465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stacking Ensemble of Disproportionality Indicators for Adverse Vaccine Reactions Detection-An Empirical Study on Predicting Adverse Reactions of COVID-19 Vaccines.
    Zhang BX; Lin WY; Huang TK
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38082660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety signal detection with control of latent factors.
    Tan X; Wang W; Zeng D; Liu GF; Diao G; Jafari N; Alt EM; Ibrahim JG
    Stat Med; 2024 Mar; 43(7):1397-1418. PubMed ID: 38297431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misinformation and the Vaccine Adverse Event Reporting System.
    Jamieson KH; Johnson KB; Cappola AR
    JAMA; 2024 Mar; 331(12):1005-1006. PubMed ID: 38407864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near real-time vaccine safety surveillance using electronic health records-a systematic review of the application of statistical methods.
    Leite A; Andrews NJ; Thomas SL
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25(3):225-37. PubMed ID: 26817940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for delayed immunization among children in an HMO.
    Lieu TA; Black SB; Ray P; Chellino M; Shinefield HR; Adler NE
    Am J Public Health; 1994 Oct; 84(10):1621-5. PubMed ID: 7943481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world evidence of autoimmune hepatitis following COVID-19 vaccination: A population-based pharmacovigilance analysis.
    Chen C; Xie D; Xiao J
    Front Pharmacol; 2023; 14():1100617. PubMed ID: 37124218
    [No Abstract]   [Full Text] [Related]  

  • 10. Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system.
    Chen C; Fu F; Ding L; Fang J; Xiao J
    Front Immunol; 2022; 13():938322. PubMed ID: 36172346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis.
    Xie J; Codd C; Mo K; He Y
    PLoS One; 2016; 11(10):e0164792. PubMed ID: 27749923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza immunization during pregnancy: Benefits for mother and infant.
    Sakala IG; Honda-Okubo Y; Fung J; Petrovsky N
    Hum Vaccin Immunother; 2016 Dec; 12(12):3065-3071. PubMed ID: 27494630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention.
    Moro PL; Li R; Haber P; Weintraub E; Cano M
    Expert Opin Drug Saf; 2016 Sep; 15(9):1175-83. PubMed ID: 27268157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thimerosal-Preserved Hepatitis B Vaccine and Hyperkinetic Syndrome of Childhood.
    Geier DA; Kern JK; Hooker BS; Sykes LK; Geier MR
    Brain Sci; 2016 Mar; 6(1):. PubMed ID: 26999226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thimerosal-containing hepatitis B vaccination and the risk for diagnosed specific delays in development in the United States: a case-control study in the vaccine safety datalink.
    Geier DA; Kern JK; Hooker BS; King PG; Sykes LK; Geier MR
    N Am J Med Sci; 2014 Oct; 6(10):519-31. PubMed ID: 25489565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disorders.
    Geier DA; Hooker BS; Kern JK; King PG; Sykes LK; Geier MR
    Int J Environ Res Public Health; 2014 Sep; 11(9):9156-70. PubMed ID: 25198681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States.
    Geier DA; Hooker BS; Kern JK; King PG; Sykes LK; Geier MR
    Transl Neurodegener; 2013 Dec; 2(1):25. PubMed ID: 24354891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A probabilistic model for reducing medication errors.
    Nguyen PA; Syed-Abdul S; Iqbal U; Hsu MH; Huang CL; Li HC; Clinciu DL; Jian WS; Li YC
    PLoS One; 2013; 8(12):e82401. PubMed ID: 24312659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.
    Martin D; Menschik D; Bryant-Genevier M; Ball R
    Drug Saf; 2013 Jul; 36(7):547-56. PubMed ID: 23657824
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.